The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,570.00
Bid: 1,550.00
Ask: 1,590.00
Change: -10.00 (-0.63%)
Spread: 40.00 (2.581%)
Open: 1,545.00
High: 1,570.00
Low: 1,545.00
Prev. Close: 1,580.00
CER Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

1 Feb 2024 15:30

RNS Number : 7610B
Cerillion PLC
01 February 2024
 

AIM: CER

Cerillion plc

("Cerillion" or "the Company")

Result of AGM

 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce that at the Company's Annual General Meeting, held today, resolutions 1 to 8 were passed as ordinary resolutions and resolutions 9 to 11 were passed as special resolutions.

 

The text of all the resolutions is contained in the Company's Notice of Annual General Meeting. The results of the polls taken on the resolutions are as follows:

 

Resolution

In favour

Percentage

In favour

Against

Percentage

Against

Withheld

Total votes

Cast (excluding withheld)

1 - Adoption of Accounts

22,212,750

100.00%

0

0.00%

3,699

22,212,750

2 - Directors' Remuneration Report

22,202,459

99.97%

6,866

0.03%

7,124

22,209,325

3 - Dividend declaration

22,213,867

100.00%

0

0.00%

2,582

22,213,867

4 - Re-election of Alan Howarth

20,847,510

95.22%

1,046,551

4.78%

322,388

21,894,061

5 - Auditor reappointment

22,212,413

99.99%

1,622

0.01%

2,414

22,214,035

6 - Auditor remuneration

22,212,572

100.00%

178

0.00%

3,699

22,212,750

7 - Authority to incur political expenditure

18,712,455

84.23%

3,503,994

15.77%

0

22,216,449

8 - Authority to allot shares

22,203,399

99.96%

8,732

0.04%

4,318

22,212,131

9 - Authority to disapply pre-emption rights

21,887,407

98.54%

323,724

1.46%

5,318

22,211,131

10 - Authority to allot equity securities

21,887,407

98.54%

323,724

1.46%

5,318

22,211,131

11 - Authority to make market purchases of own shares

22,216,277

100.00%

172

0.001%

0

22,216,449

 

The person who arranged for the release of this announcement was Alan Howarth, Chairman.

 

For further information please contact:

 

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Ben Cryer, Matthew Hogg

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

About Cerillion

www.cerillion.com

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has c.80 customer installations across c.45 countries. Headquartered in London, Cerillion also has operations in India and in Bulgaria.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBUGDDRDGDGSB
Date   Source Headline
22nd Apr 20247:00 amRNSTrading Update
13th Mar 20247:00 amRNSShare Purchase
13th Feb 20245:27 pmRNSTR-1 Notification
13th Feb 20245:22 pmRNSTR-1
1st Feb 20243:30 pmRNSResult of AGM
15th Dec 20234:15 pmRNSPosting of Annual Report and Notice of AGM
21st Nov 20235:34 pmRNSPDMR Shareholding
20th Nov 20237:00 amRNSFinal Results
17th Nov 20237:00 amRNSNotice of Results and Online Presentation
7th Nov 20237:00 amRNSLatest product release incorporates Generative AI
2nd Nov 20237:00 amRNSMajor new customer win with Tier-1 Telco
16th Oct 20237:00 amRNSTrading Update
25th Sep 202311:53 amRNSHolding(s) in Company
6th Jul 20237:00 amRNSCompletion of Initial Implementation at Telesur
21st Jun 20237:00 amRNSMajor new contract
22nd May 20237:00 amRNSGartner Market Guide Reports
15th May 20237:00 amRNSHalf-year Report
4th May 20237:00 amRNSDate of Interim Results and Investor Presentation
17th Apr 20237:00 amRNSH1 2023 Trading Update
31st Mar 20237:00 amRNSMajor New Contract
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:32 pmRNSHolding(s) in Company
21st Feb 20237:00 amRNSCompletion of Major Implementation
2nd Feb 20232:19 pmRNSResult of AGM
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20227:00 amRNSGrant of Options and PDMR Shareholding
15th Dec 20225:20 pmRNSHolding(s) in Company
2nd Dec 20222:35 pmRNSHolding(s) in Company
30th Nov 20226:29 pmRNSPDMR and PCA shareholding
30th Nov 202211:18 amRNSHolding(s) in Company
28th Nov 20227:00 amRNSFinal Results
23rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
2nd Nov 20225:49 pmRNSHolding(s) in Company
2nd Nov 202212:40 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSRelease of latest version of flagship product set
24th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSAppointment of Joint Broker
25th Aug 20223:48 pmRNSGrant of Options
8th Aug 20223:08 pmRNSHolding(s) in Company
28th Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20227:00 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSMajor Contract Win
13th May 20227:33 amRNSDirector Share Purchase
9th May 20227:00 amRNSInterim Results Presentation
9th May 20227:00 amRNSInterim Results
25th Apr 202210:13 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSH1 2022 Trading Update
6th Apr 20227:00 amRNSCerillion Client MVN-X Reaches Million Subscribers
7th Mar 20227:00 amRNSWins Prestigious Megabuyte Performance Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.